Literature DB >> 29679258

The growing burden of liver cirrhosis: implications for preventive measures.

Martin C S Wong1,2,3, Junjie Huang4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29679258     DOI： 10.1007/s12072-018-9865-y

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  12 in total

1.  Implementation of the Lancet Standing Commission on Liver Disease in the UK.

Authors:  Roger Williams; Kathryn Ashton; Richard Aspinall; Mark A Bellis; Joanne Bosanquet; Matthew E Cramp; Natalie Day; Anil Dhawan; John Dillon; Jessica Dyson; James Ferguson; Graham Foster; Sir Ian Gilmore; Michael Glynn; J Ashley Guthrie; Mark Hudson; Deirdre Kelly; Andrew Langford; Philip Newsome; John O'Grady; Rachel Pryke; Stephen Ryder; Marianne Samyn; Nick Sheron; Julia Verne
Journal:  Lancet       Date:  2015-11-20       Impact factor: 79.321

2.  Liver cirrhosis and cancer: comparison of mortality.

Authors:  Wankyo Chung; Changik Jo; Woo Jin Chung; Dong Joon Kim
Journal:  Hepatol Int       Date:  2018-03-01       Impact factor: 6.047

Review 3.  Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.

Authors:  Jürgen Rehm; Benjamin Taylor; Satya Mohapatra; Hyacinth Irving; Dolly Baliunas; Jayadeep Patra; Michael Roerecke
Journal:  Drug Alcohol Rev       Date:  2010-07

Review 4.  Liver cirrhosis.

Authors:  Detlef Schuppan; Nezam H Afdhal
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

Review 5.  Cirrhosis and its complications: evidence based treatment.

Authors:  Salman Nusrat; Muhammad S Khan; Javid Fazili; Mohammad F Madhoun
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

6.  New metrics for the Lancet Standing Commission on Liver Disease in the UK.

Authors:  Roger Williams; Graeme Alexander; Richard Aspinall; Joanne Bosanquet; Ginette Camps-Walsh; Matthew Cramp; Natalie Day; Anil Dhawan; John Dillon; Jessica Dyson; James Ferguson; Graham Foster; Richard Gardner; Sir Ian Gilmore; Lesley Hardman; Mark Hudson; Deirdre Kelly; Andrew Langford; Stephen Liversedge; Kieran Moriarty; Philip Newsome; John O'Grady; Rachel Pryke; Liz Rolfe; Harry Rutter; Stephen Ryder; Marianne Samyn; Nick Sheron; Alison Taylor; Jeremy Thompson; Julia Verne; Andrew Yeoman
Journal:  Lancet       Date:  2016-12-16       Impact factor: 79.321

Review 7.  Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.

Authors:  Roger Williams; Richard Aspinall; Mark Bellis; Ginette Camps-Walsh; Matthew Cramp; Anil Dhawan; James Ferguson; Dan Forton; Graham Foster; Ian Gilmore; Matthew Hickman; Mark Hudson; Deirdre Kelly; Andrew Langford; Martin Lombard; Louise Longworth; Natasha Martin; Kieran Moriarty; Philip Newsome; John O'Grady; Rachel Pryke; Harry Rutter; Stephen Ryder; Nick Sheron; Tom Smith
Journal:  Lancet       Date:  2014-11-29       Impact factor: 79.321

8.  International incidence and mortality trends of liver cancer: a global profile.

Authors:  Martin C S Wong; Johnny Y Jiang; William B Goggins; Miaoyin Liang; Yuan Fang; Franklin D H Fung; Colette Leung; Harry H X Wang; Grace L H Wong; Vincent W S Wong; Henry L Y Chan
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

9.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

10.  The global burden of liver disease: a challenge for methods and for public health.

Authors:  Peter Byass
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775
View more
  12 in total

1.  Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis.

Authors:  Junjie Huang; Veeleah Lok; Chun Ho Ngai; Cedric Chu; Harsh K Patel; Viveksandeep Thoguluva Chandraseka; Lin Zhang; Ping Chen; Shanjuan Wang; Xiang-Qian Lao; Lap Ah Tse; Wanghong Xu; Zhi-Jie Zheng; Martin C S Wong
Journal:  Liver Cancer       Date:  2021-03-30       Impact factor: 11.740

2.  Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study.

Authors:  Reham S Ibrahim; Nesrine S El-Mezayen; Alaa A El-Banna
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

3.  Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice.

Authors:  Jessica Mae Grindheim; Dario Nicetto; Greg Donahue; Kenneth S Zaret
Journal:  Gastroenterology       Date:  2019-01-25       Impact factor: 22.682

4.  Differences in parents of pediatric liver transplantation and chronic liver disease patients.

Authors:  Sami Akbulut; Gulsen Gunes; Hasan Saritas; Bahar Aslan; Yunus Karipkiz; Khaled Demyati; Sukru Gungor; Sezai Yilmaz
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

5.  Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case-control study.

Authors:  Christian S Alvarez; Elisa Hernández; Kira Escobar; Carmen I Villagrán; María F Kroker-Lobos; Alvaro Rivera-Andrade; Joshua W Smith; Patricia A Egner; Mariana Lazo; Neal D Freedman; Eliseo Guallar; Michael Dean; Barry I Graubard; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  BMJ Open Gastroenterol       Date:  2020-07

6.  Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.

Authors:  Won Young Jang; Woo Jin Chung; Byoung Kuk Jang; Jae Seok Hwang; Heon Ju Lee; Moon Joo Hwang; Young Oh Kweon; Won Young Tak; Soo Young Park; Su Hyun Lee; Chang Hyeong Lee; Byung Seok Kim; Si Hye Kim; Jeong Ill Suh; Jun Gi Park
Journal:  J Korean Med Sci       Date:  2020-07-27       Impact factor: 2.153

Review 7.  Therapeutic Effect of Tanshinone IIA on Liver Fibrosis and the Possible Mechanism: A Preclinical Meta-Analysis.

Authors:  Qingji Ying; Yangyang Teng; Jing Zhang; Zhenzhai Cai; Zhanxiong Xue
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-13       Impact factor: 2.629

8.  Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.

Authors:  Su Lin Lim; Jolyn Johal; Kai Wen Ong; Chad Yixian Han; Yiong Huak Chan; Yin Mei Lee; Wai Mun Loo
Journal:  JMIR Mhealth Uhealth       Date:  2020-04-13       Impact factor: 4.773

9.  A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy.

Authors:  Aisha Vadhariya; Hua Chen; Omar Serna; Hani Zamil; Susan M Abughosh
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

10.  Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells.

Authors:  Hae Lim Lee; Jungmin Lee; Jung Hoon Cha; Sungwoo Cho; Pil Soo Sung; Wonhee Hur; Seung Kew Yoon; Si Hyun Bae
Journal:  Korean J Intern Med       Date:  2021-07-29       Impact factor: 2.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.